Upload
santa-kumar
View
242
Download
0
Embed Size (px)
Citation preview
8/6/2019 ImmunoAssay Protocol
1/31
Introduction of Immunoassay
8/6/2019 ImmunoAssay Protocol
2/31
Immuno & Assay
Immuno refers to an immune response that causes the body to
generate antibodies,
Assay refers to a test. Thus, an immunoassay is a test that
utilizes immunocomplexing when antibodies and antigens are
brought together
8/6/2019 ImmunoAssay Protocol
3/31
Immunoassays are a group of sensitive analytical tests that
utilize very specific antibody/antigen complexes to produce a
signal that can be measured and related to the concentration of
a compound in solution. Immunoassays also produce
qualitative data in terms of the presence (+) or absence (-) of a
compound in the body.
They are used in a lot of laboratories, including hospitals labs,
and have been widely used in the special area of Forensic
Toxicology to screen for drugs and other chemicals in the
body
8/6/2019 ImmunoAssay Protocol
4/31
Definition of antibody
Know that antibodies are proteins that are found in blood or
other bodily fluids that are used by the immune system to
identify and neutralize foreign objects, such as bacteria and
viruses.
Antibodies are produced by the B lymphocytes. They areglycoproteins belonging to the immunoglobulin supergene
family that are produced in response to a foreign substance in
the body.
Antibodies have a generally common structure, but have
regions that vary among them to accommodate the specific
antigens.
8/6/2019 ImmunoAssay Protocol
5/31
Definition of antigen
Know that an antigen is any substance that causes your
immune system to produce antibodies against it. An antigen
may be a foreign substance from the environment such as
chemicals, bacteria, viruses, or pollen; they may also be
produced inside the body.
An antigen is a substance with the ability to induce an
immunological response. They typically enter the body from
an infection. They are recognized at their epitopes by B cells
or by the T cell receptor on T cells.
8/6/2019 ImmunoAssay Protocol
6/31
Proteins or glycoproteins make the best antigens because they
are the best at stimulating antigen recognition molecules.
Some immunoassays test for antigens, rather than antibodies .
8/6/2019 ImmunoAssay Protocol
7/31
Monoclonal Antibodies
Monoclonal antibodies differ from polyclonal antibodies in
that they are highly specific for a single epitope on a
multivalent antigen .
8/6/2019 ImmunoAssay Protocol
8/31
Polyclonal Antibodies
Antiserum usually contains a mixture of antibodies that
recognize and bind to the same antigen, but they may attach to
different epitopes. An antigen that has multiple sites for
antibodies to bind is called a multivalent antigen.
These types of antibodies, present as a diverse mixture, are
called Polyclonal antibodies.
8/6/2019 ImmunoAssay Protocol
9/31
Immunoassay methods evaluation
Introduction
Selection of an analytical methods which meets the clinical
laboratorys objectives of reliable,accurate,timely and cost-
effective service is essential.
Evaluation of Immunoassays requires an efficient protocol and
objective criteria for method selection.
8/6/2019 ImmunoAssay Protocol
10/31
Protocol can easily be modified, depending on the specific
questions being asked .
Appropriate application of the tests described here depends on
a thorough understanding of the analytic and bio chemical
principles involved in the use of the antigen antibody reaction.
8/6/2019 ImmunoAssay Protocol
11/31
A. Specific Laboratory Objectives for
M
ethod Evaluation Before evaluating a new method or starting a new test number
of requests expected to establish clinical need.
New method with convenient timing may result in inefficient
turn and around affect overall service by reducing the number
of other laboratory tests ordered or repeated.
Some methods offer increased sensitivity and specificity
highly purified or unique standards or easy to use formats
8/6/2019 ImmunoAssay Protocol
12/31
B.Analytical Objectives
The analytical terms precision accuracy and sensitivity
specificity have well defined meanings in anlytical and
clinical chemistry.
But because of the unique characteristics of immunoassays,
these concepts can be complex. Eg. Both accuracy and assay
sensitivity may be limited by precision.
In the current context analytical sensitivity and specificity are
distinguished from the concepts of clinical sensitivity and
specificity.
8/6/2019 ImmunoAssay Protocol
13/31
Assay characteristics described above are analytical goals
shared by all clinical laboratories.
How well on assay achieves them depends on the unique
characteristics of the reagents and on experimental
optimization.
8/6/2019 ImmunoAssay Protocol
14/31
Protocol Outline
A. Objectives and preparation for evaluation.
B. Precision.
C. Standard curves : shape, data reduction ,matrix ,interferences.
D. Tracer- immunoreactivity, specific activity.
E. Sensitivity.
F. Accuracy: Parallelism ,recovery,cross-reactivity.
G. Seatchard plot.
H. Clinical validation. (OPSTSASC)
8/6/2019 ImmunoAssay Protocol
15/31
Establishing objectives and preparation
A.Protocol Review
The first step is to read the manufacturers claim carefully.
The statement is equivalent to ones mothers reminder to
galoshes.
But a great deal of trouble can be avoided and questions
answered before a single reagent is pipetted.
A thorough review of the protocol includes careful attention to
timing,temperature and centrifuge.
8/6/2019 ImmunoAssay Protocol
16/31
1.Precision
Compare claims of precision between kits.
Surprisingly,you may have to check the calculations.
8/6/2019 ImmunoAssay Protocol
17/31
2.Standard Curves
Standard curves are usually illustrated . Sensitivity,range and
shapes can be compared by plotting data from different kits on
the same scale.
This simple procedure may uncover strengths or weaknesses
of one kit or another which may then be investigated further.
Precision and sensitivity of the curve in the region of the upper
limit of normal are extremely important.
8/6/2019 ImmunoAssay Protocol
18/31
3.Reagents
Information on the source and chemical structure of the
antigens,antibodies and tracers can be related to the specificity
expected and can direct attention to certain problems which
may be anticipated.
Antibody.
Antigen.
Tracer.
Standard.
8/6/2019 ImmunoAssay Protocol
19/31
B.Information and Planning
Consultation with other users of a method and review of its
performance in proficiency survey and quality control
programs provide moral support and consensus of its
popularity , precision and any systematic bias.
To evaluate a kit efficiently and to make objective
comparisons between methods. Adequate quality control
materials ,standards and previously assay samples shold be
obtained and stored in aliquots.
8/6/2019 ImmunoAssay Protocol
20/31
Evaluation of Precision
Precision is a statistical index of the ability of an assay to yield
the same result when the assay is repeated on the same sample.
A.Definition
1. Within run precision : It is defined as the precision of the
same sample run several times in the same assay.
2. Between-run precision : It is an index of the ability of the
assay to reproduce a result on the same sample from day to
day, or the confidence interval about a single result.
8/6/2019 ImmunoAssay Protocol
21/31
B. Protocol for precision studies
1. Materials : Fresh samples are often more stable and results
are more precise than those obtainable on reconstituted
serum.
2. Concentration to use : Samples for precision studies are
usually used in atleast three concentrations.
Generally the levels selected represent low (80% Bo).
Midrange (50% Bo or ED50) and high (20% Bo) doses on
the standard curve.
8/6/2019 ImmunoAssay Protocol
22/31
3.Calculations:
Average deviation : It is the measurements of a set is the mean
of the difference of the individual measurements without
regard to sign .
Standard deviation : Selected test samples are assayed in two
or more replicates in every run. Results are obtained from
standard curve and tabulated.
8/6/2019 ImmunoAssay Protocol
23/31
4. Acceptable performance:
A question often asked What is acceptable precision? High
precision is particularly important in the concentration range
of critical clinical decisions.
Certainly single laboratory should get standard deviations as
low as or less than those stated by the reagent manufacturer
8/6/2019 ImmunoAssay Protocol
24/31
C.Precision profile
The response (bound label or some function of bound label)
measured in immunoassays is nonlinear and the variance is
nonuniform : that is, the precision is different at different
analyte concentrations. This is called heteroscadasticity.
A device for expressing overall performance is the precision
profile a graph of coefficient of variation against
concentration of analyte .
8/6/2019 ImmunoAssay Protocol
25/31
In its simplest form the precision profile is created by assaying
many replicates of standards and plotting the CV against the
known concentrations .
The performance over the entire curve and any existing
heteroscadasticity can be visualized.
To calculate the CV for the CV versus those graph obsevations
on patients are grouped orbinned into dose ranges and the
mean concentration and mean CV used for profile.
8/6/2019 ImmunoAssay Protocol
26/31
D.Sources of Imprecision
Aside from assessing precision it is important during
evaluation to reduce the both random and systematic errors to
the minimum by adherence to the manufacturers procedures
and by careful calibrations and quality control of all
instruments in the laboratory.
1. Kit components and protocol:
Although the selection of antibody , separation method and
method design and optimization are out of the control of the
user.
8/6/2019 ImmunoAssay Protocol
27/31
The effect of this choice is felt by the laboratory.
Source of variation(Random and /or systematic)
Source of error effect on assay
1. Pipetting Accuracy
Precision
Carry over
8/6/2019 ImmunoAssay Protocol
28/31
2. Separation Reagents
Reaction
Timing
Stripping
NSB effects
3.Chemistry Reagents
Reaction(EquilibriumVs non equilibrium )
8/6/2019 ImmunoAssay Protocol
29/31
4. Counting Total Counts
Instrumental QC
Geometry
Quench
5. Color reaction Interference
Stability
8/6/2019 ImmunoAssay Protocol
30/31
Sources of Error: Non isotopic assays
Source of error Effect on assay
1.Interferences Add color or reduce color etc.,
2.Color reaction Stability of substrate
Colored product
3.Precision Timing
Washing
Separation
Spectrophotometric error
Binding reaction
8/6/2019 ImmunoAssay Protocol
31/31
Thank you